Roger Garceau

Dr. Roger Garceau has served on Protara’s board of directors since January 2019 and has more than 30 years of broad pharmaceutical industry experience in drugs, biologics and combination drug/device products for orphan and non-orphan indications, both in the U.S. and Internationally. He previously served as Chief Medical Officer and Executive Vice President of NPS Pharmaceuticals, Inc. since December 2008 and January 2013 respectively, until February 2015, when NPS Pharmaceuticals was acquired by Shire plc. At NPS Dr. Garceau led two successful orphan products through filing, Advisory Committees and registrations. Previously, he served in several managerial positions with NPS Pharmaceuticals, Inc., Sanofi-Aventis and Pharmacia Corporation. He has been a non-executive director of Enterome SA since December 2016 and Entera Bio since March 2016. Dr. Garceau is a board-certified pediatrician and is a Fellow of the American Academy of Pediatrics. He holds a BS in Biology from Fairfield University in Fairfield, Connecticut and an MD from the University of Massachusetts Medical School.